Page last updated: 2024-09-03

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 3 studies

Compound Research Comparison

Studies
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)
Trials
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)
Recent Studies (post-2010)
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)
Studies
(2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
Trials
(2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
Recent Studies (post-2010) (2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
19001,2160229

Protein Interaction Comparison

ProteinTaxonomy5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate (IC50)2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 2Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 3Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 4Rattus norvegicus (Norway rat)0.5781
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)2.909
Glutamate receptor 1Homo sapiens (human)6
Glutamate receptor 2Homo sapiens (human)2.5
Glutamate receptor 3Homo sapiens (human)1.9
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)2.909
Glutamate receptor 4Homo sapiens (human)1.1
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.2

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Browne, SE; Bullock, R; Dawson, D; Fujisawa, H; MacKay, KB; McCulloch, J1
Gaspary, HL; Graham, SH; Simon, RP1
al-Zubaidy, ZA; Chapman, AG; Meldrum, BS; Smith, SE1

Other Studies

3 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ArticleYear
Pharmacological modification of glutamate neurotoxicity in vivo.
    Brain research, 1993, Nov-26, Volume: 629, Issue:1

    Topics: Amino Acid Oxidoreductases; Animals; Arginine; Benzofurans; Blood Pressure; Brain Ischemia; Cerebral Cortex; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Male; Microdialysis; Neurons; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrimidines; Pyrrolidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors

1993
BW1003C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis.
    European journal of pharmacology, 1994, Sep-12, Volume: 262, Issue:3

    Topics: Analysis of Variance; Animals; Binding, Competitive; Brain Ischemia; Disease Models, Animal; Glutamic Acid; Hippocampus; Injections, Intraperitoneal; Injections, Intravenous; Male; Microdialysis; N-Methylaspartate; Necrosis; Neurons; Observer Variation; Pipecolic Acids; Prosencephalon; Pyrimidines; Quinoxalines; Random Allocation; Rats; Rats, Wistar; Receptors, AMPA; Reperfusion Injury

1994
Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat.
    Epilepsy research, 1993, Volume: 15, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Acoustic Stimulation; Amino Acids; Amino Acids, Cyclic; Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Diazepam; Disease Models, Animal; Dizocilpine Maleate; Epilepsy; Female; Lamotrigine; Male; Motor Activity; Phenytoin; Pyrimidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors; Triazines

1993